Frontage-Quanterix Joint Webinar
Join Frontage Laboratories and Quanterix for a joint webinar highlighting the application of ultra-sensitive immunoassay platforms in biomarker development. This session will feature a case study led by Dr. Jingwen Tan, Director of Biomarker Services at Frontage, showcasing the validation of an IL-17A assay in human serum using Quanterix’s Simoa® technology.
Dr. Tan will share insights from a recent validation study, demonstrating the platform’s exceptional sensitivity, reproducibility, and robustness for cytokine quantitation—critical for therapeutic monitoring and drug development. The presentation will also cover the complete validation workflow and key analytical performance metrics.
Dr. Wesley Straub, VP of Product Management at Quanterix, will provide an overview of the Simoa Cytokine Advantage PLUS product line and its broad utility across multiple therapeutic areas.
Whether you’re part of a pharmaceutical, biotech, or academic team, this webinar offers practical guidance on integrating high-sensitivity multiplexing into biomarker programs to overcome limitations of traditional immunoassays.
________________________________________
What You’ll Learn:
• How Frontage validated an ultra-sensitive IL-17A assay using Simoa® for serum-based applications
• Key performance metrics including sensitivity, reproducibility, and matrix effect evaluation
• Use cases of Simoa cytokine assays in immuno-oncology, autoimmunity, and infectious disease research
• How Simoa compares to other multiplex platforms in terms of sensitivity and scalability
• Implementation strategies for integrating Simoa assays into CRO and sponsor biomarker pipelines
________________________________________
Speakers:
Jingwen Tan, Ph.D.
Director of Biomarker Services, Frontage Laboratories
Dr. Jingwen Tan leads biomarker and bioanalytical innovation. With over a decade of experience in chemical engineering, biomaterials, and translational neuroscience, she brings a multidisciplinary perspective to bioanalytical assay development. Notably, Dr. Tan specializes in ultra-sensitive assay validation that helps to detect biomarkers at low levels; critical for advancing drug development and clinical research. In this webinar, Dr. Tan will walk us through what makes ultra-high sensitive bioanalytical assays so powerful, how they’re developed and validated, and how the validated assay can support laboratory and clinical research.
Wesley Straub, Ph.D.
VP, Product Management, Quanterix
Dr. Straub has extensive experience leading life science product development across multiple assay platforms. At Quanterix, he oversees strategic product development of the Simoa® portfolio.